Comparisons of cystatin C with creatinine for evaluation of renal function in chronic kidney disease

Clinical and Experimental Nephrology

Volumn 13, Issue 6, 2009, Pages 598-604

  Yashiro, Masatomo ^a   Kamata, Tadashi ^a   Segawa, Hiroyoshi ^a   Kadoya, Yuko ^a   Murakami, Toru ^a   Muso, Eri ^b  

^a KYOTO CITY HOSPITAL   (Japan)

^b Kitano Hospital   (Japan)

Author keywords

CKD; Creatinine; Cystatin C; Renal function

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; PREDNISOLONE;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEXUAL DEVELOPMENT; SMOKING;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATININE; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREDNISOLONE; RENAL INSUFFICIENCY, CHRONIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SMOKING;

EID: 76249120291     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-009-0202-6     Document Type: Article

References (21)

1. Hoek FJ, Kemperman FAW, Kredit RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant. 2003;18:2024-31. (Pubitemid 37220307)
2. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830.
3. Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med. 1999;246:247-52. (Pubitemid 29426443)
4. Simonsen O, Grubb A, Thysell H. The blood serum concentration of cystatin C (γ-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest. 1985;45:97-101. (Pubitemid 15106618)
5. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem. 2000;37:49-59. (Pubitemid 30064225)
6. Norlund L, Fex G, Lanke J, Von Schenck H, Nilsson JE, Leksell H, et al. Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio. Scand J Clin Lab Invest. 1997;57:463-70. (Pubitemid 27443517)
7. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest. 1999;59:587-92. (Pubitemid 30082117)
8. Pucci L, Triscornia S, Lucchesi D, Fotino C, Pellegrini G, Pardini E, et al. Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients. Clin Chem. 2007;26:480-8. (Pubitemid 46447945)
9. O'Riordan S, Ouldred E, Brice S, Jackson SH, Swift CG. Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. Br J Clin Pharmacol. 2002;53:398-402. (Pubitemid 34415592)
10. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant. 2007;22:1087-92. (Pubitemid 46523422)
11. Xu H, Lu Y, Teng D, Wang J, Wang L, Li Y. Assessment of glomerular filtration rate in renal transplant patients using serum cystatin C. Transplant Proc. 2006;38:2006-8. (Pubitemid 46068554)
12. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416-21. (Pubitemid 38406982)
13. Donahue RP, Stranges S, Rejman K, Rafalson LB, Dmochowski J, Trevisan M. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study. Diabetes Care. 2007;30:1724-9. (Pubitemid 47036343)
14. Tanaka M, Matsuo K, Enomoto M, Mizuno K. A sol particle homogeneous immunoassay for measuring serum cystatin C. Clin Biocem. 2004;37:27-35. (Pubitemid 37522122)
15. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007;50:927-37. (Pubitemid 350130278)
16. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, et al. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007;11:156-63. (Pubitemid 47012510)
17. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-77. (Pubitemid 23118304)
18. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-47.
19. Coll E, Botey A, Alvarez L, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000;36:29.
20. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40:221.
21. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395-406. (Pubitemid 351273480)